Showing results (2361-2370 of 2,674) with videos related to
Sort By:
Pageof 268
American Journal of Respiratory and Critical Care Medicine|October 8, 2020
Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic FibrosisLucy Perrem, Sanja Stanojevic, Michelle Shaw, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancerThomas John, Otavia L Caballero, Suzanne J Svobodová, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trialCora N Sternberg, Ian D Davis, Jozef Mardiak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2023
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III TrialCora N Sternberg, Ian D Davis, Jozef Mardiak, et al.Nutrients|November 27, 2025
Effect of Exogenous Ketones as an Adjunct to Low-Calorie Diet on Metabolic MarkersEliza J Roeth, Genevieve Parker, Ella F Cooper-Leavitt, et al.Microbiology Spectrum|June 30, 2025
Effects of low wildfire burn severity due to pre-fire shrub thinning on the chaparral soil bacteriome in the Santa Monica Mountains of Southern CaliforniaMariah Macias, Mari R Irving, Katelyn M Bandow, et al.OTO Open|February 24, 2025
Progression of Otologic and Nasal Symptoms in Primary Ciliary Dyskinesia Throughout ChildhoodIsabelle Dagher, Adam J Kimple, Thomas W Ferkol, et al.European Urology Oncology|October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 7, 2020
A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacyA S Paller, E C Siegfried, E L Simpson, et al.Respiratory Physiology & Neurobiology|June 22, 2021
Lung inflammation and simulated airway resistance in infants with cystic fibrosisEmily M DeBoer, Julia S Kimbell, Kaci Pickett, et al.Pageof 268